Cargando…

A Cost-Effectiveness Analysis of First Trimester Non-Invasive Prenatal Screening for Fetal Trisomies in the United States

BACKGROUND: Non-invasive prenatal testing (NIPT) is a relatively new technology for diagnosis of fetal aneuploidies. NIPT is more accurate than conventional maternal serum screening (MSS) but is also more costly. Contingent NIPT may provide a cost-effective alternative to universal NIPT screening. C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Walker, Brandon S., Nelson, Richard E., Jackson, Brian R., Grenache, David G., Ashwood, Edward R., Schmidt, Robert L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489811/ https://www.ncbi.nlm.nih.gov/pubmed/26133556 http://dx.doi.org/10.1371/journal.pone.0131402

Ejemplares similares

Non-Invasive Epigenetic Detection of Fetal Trisomy 21 in First Trimester Maternal Plasma
por: Lim, Ji Hyae, et al.
Publicado: (2011)

An efficient method for noninvasive prenatal diagnosis of fetal trisomy 13, trisomy 18, and trisomy 21
por: Sun, Xiaohan, et al.
Publicado: (2019)

Non-Invasive Prenatal Testing of Trisomy 18 by an Epigenetic Marker in First Trimester Maternal Plasma
por: Lee, Da Eun, et al.
Publicado: (2013)

A Cost-Effectiveness Analysis of Screening Strategies Involving Non-Invasive Prenatal Testing for Trisomy 21
por: Wang, Shuxian, et al.
Publicado: (2022)

Noninvasive Prenatal Diagnosis of Fetal Trisomy 18 and Trisomy 13 by Maternal Plasma DNA Sequencing
por: Chen, Eric Z., et al.
Publicado: (2011)

Non-invasive prenatal test to screen common trisomies in twin pregnancies
por: Motevasselian, Mahtab, et al.
Publicado: (2020)

Non-invasive prenatal diagnosis of fetal trisomy 21 using cell-free fetal DNA in maternal blood
por: Lim, Ji Hyae, et al.
Publicado: (2013)

Fetal cystic hygroma in the first trimester led to diagnosis of partial trisomy 22
por: Phupong, Vorapong, et al.
Publicado: (2021)

Disease specific characteristics of fetal epigenetic markers for non-invasive prenatal testing of trisomy 21
por: Lim, Ji Hyae, et al.
Publicado: (2014)

Non-Invasive Prenatal Testing beyond Trisomies
por: Suciu, Ioan Dumitru, et al.
Publicado: (2019)

Application of an individualized nomogram in first‐trimester screening for trisomy 21
por: Sun, Y., et al.
Publicado: (2021)

Prenatal screening for trisomy 21: a comparative performance and cost analysis of different screening strategies
por: Huang, Tianhua, et al.
Publicado: (2020)

Fetal fraction‐based risk algorithm for non‐invasive prenatal testing: screening for trisomies 13 and 18 and triploidy in women with low cell‐free fetal DNA
por: McKanna, T., et al.
Publicado: (2018)

Usefulness and reliability of cell free fetal DNA screening for main trisomies in case of atypical profile on first trimester maternal serum screening
por: Carrara, Julie, et al.
Publicado: (2019)

The significance of trisomy 7 mosaicism in noninvasive prenatal screening
por: Qi, Yiming, et al.
Publicado: (2019)

Introducing the non-invasive prenatal test for trisomy 21 in Belgium: a cost-consequences analysis
por: Neyt, Mattias, et al.
Publicado: (2014)

Fetal Nasal Bone Status In Iranian Women Undergoing First-Trimester Screening For Trisomy 21: A Review and an Observational Study.
por: Poureisa, Masoud, et al.
Publicado: (2015)

Cost and efficacy comparison of prenatal recall and reflex DNA screening for trisomy 21, 18 and 13
por: Bestwick, Jonathan Paul, et al.
Publicado: (2019)

MeDIP Real-Time qPCR has the Potential for Noninvasive Prenatal Screening of Fetal Trisomy 21
por: Kazemi, Mohammad, et al.
Publicado: (2017)

Comparison of two immunoassay systems for hCGβ and PAPP-A in prenatal screening for trisomy 21, 18, and 13 in the first trimester
por: Engell, Anna Elise, et al.
Publicado: (2017)

Clinical Significance of Non-Invasive Prenatal Screening for Trisomy 7: Cohort Study and Literature Review
por: Zhu, Xiaofan, et al.
Publicado: (2020)

Clinical Efficiency of Non-invasive Prenatal Screening for Common Trisomies in Low-Risk and Twin Pregnancies
por: Xu, Yanfei, et al.
Publicado: (2021)

Maternal prenatal screening programs that predict trisomy 21, trisomy 18, and neural tube defects in offspring
por: Chen, Yiming, et al.
Publicado: (2023)

Prenatal diagnosis of a trisomy 7/trisomy 13 mosaicism
por: Huijsdens-van Amsterdam, Karin, et al.
Publicado: (2012)

Clinical evaluation of the IONA test: a non‐invasive prenatal screening test for trisomies 21, 18 and 13
por: Papageorghiou, A. T., et al.
Publicado: (2015)

Comparing Non-invasive Prenatal Testing With Invasive Testing for the Detection of Trisomy 21
por: Mokhtar, Rifat, et al.
Publicado: (2022)

Second Trimester Fetal Cardiac Screening – Current Opinion
por: Bravo-Valenzuela, Nathalie Jeanne, et al.
Publicado: (2023)

Noninvasive Prenatal Screening for Trisomy 21 in Patients with a Vanishing Twin
por: Kleinfinger, Pascale, et al.
Publicado: (2022)

Prenatally Diagnosed Rare Trisomy 16 Mosaicism in Human Amniotic Fluid Cells in the Second Trimester: A Case Report
por: Kim, Sook Ryung, et al.
Publicado: (2018)

Noninvasive Fetal Trisomy (NIFTY) test: an advanced noninvasive prenatal diagnosis methodology for fetal autosomal and sex chromosomal aneuploidies
por: Jiang, Fuman, et al.
Publicado: (2012)

Combined fetal fraction to analyze the Z-score accuracy of noninvasive prenatal testing for fetal trisomies 13, 18, and 21
por: Yang, Jiexia, et al.
Publicado: (2023)

A new contingent screening strategy increased detection rate of trisomy 21 in the first trimester
por: Luo, Wei, et al.
Publicado: (2023)

Performance of non-invasive prenatal testing for trisomies 21 and 18 in twin pregnancies
por: Yang, Jiexia, et al.
Publicado: (2018)

Detection of trisomies 13, 18 and 21 using non-invasive prenatal testing
por: Qiang, Rong, et al.
Publicado: (2017)

Study on amniotic fluid metabolism in the second trimester of Trisomy 21
por: Liu, Xiaoting, et al.
Publicado: (2019)

Prenatal diagnosis of trisomy 8 mosaicism, initially identified by cffDNA screening
por: Hu, Junjie, et al.
Publicado: (2022)

First trimester diagnosis and screening for fetal aneuploidy
por: Driscoll, Deborah A., et al.
Publicado: (2008)

Evaluation of Maternal Serum sHLA-G Levels for Trisomy 18 Fetuses Screening at Second Trimester
por: Xu, Danping, et al.
Publicado: (2021)

Diagnostic value of maternal alpha-fetoprotein variants in second-trimester biochemical screening for trisomy 21 and 18
por: Chen, Yiming, et al.
Publicado: (2022)

Novel method of real-time PCR-based screening for common fetal trisomies
por: Kim, So Yeon, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_516gn5lp4cvec1ng5kjsngdafu